Actuate Therapeutics Inc

Actuate Therapeutics Incverified

ACTU

Price:

$6.08

Market Cap:

$119.29M

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.

Industry

Biotechnology

IPO Date

2024-08-13

Stock Exchange

NASDAQ

Ticker

ACTU

The ROE as of July 2025 (TTM) for Actuate Therapeutics Inc (ACTU) is 88.89%

According to Actuate Therapeutics Inc’s latest financial reports and current stock price. The company's current ROE is 88.89%. This represents a change of -105.76% compared to the average of -1542.15% of the last 4 quarters.

Actuate Therapeutics Inc (ACTU) Historical ROE (quarterly & annually)

How has ACTU ROE performed in the past?

The mean historical ROE of Actuate Therapeutics Inc over the last ten years is -8712.48%. The current 88.89% ROE has changed -101.02% with respect to the historical average. Over the past ten years (40 quarters), ACTU's ROE was at its highest in in the March 2025 quarter at 124.16%. The ROE was at its lowest in in the December 2024 quarter at -6187.10%.

Quarterly (TTM)
Annual

Average

-8712.48%

Median

24.84%

Minimum

-26189.05%

Maximum

26.77%

Actuate Therapeutics Inc (ACTU) ROE by Quarter and Year

Discovering the peaks and valleys of Actuate Therapeutics Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 26.77%

Minimum Annual Increase = -105542.08%

Minimum Annual ROE = -26189.05%

Quarterly (TTM)
Annual
YearROEChange
2024-26189.05%-105542.08%
202324.84%-7.22%

Actuate Therapeutics Inc (ACTU) Average ROE

How has ACTU ROE performed in the past?

The current ROE of Actuate Therapeutics Inc (ACTU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8712.48%

5-year avg

-8712.48%

10-year avg

-8712.48%

Actuate Therapeutics Inc (ACTU) ROE vs. Peers

How is ACTU’s ROE compared to its peers?

Actuate Therapeutics Inc’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Actuate Therapeutics Inc (ACTU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actuate Therapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actuate Therapeutics Inc (ACTU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actuate Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Actuate Therapeutics Inc's ROE?

How is the ROE calculated for Actuate Therapeutics Inc (ACTU)?

What is the highest ROE for Actuate Therapeutics Inc (ACTU)?

What is the 3-year average ROE for Actuate Therapeutics Inc (ACTU)?

What is the 5-year average ROE for Actuate Therapeutics Inc (ACTU)?

How does the current ROE for Actuate Therapeutics Inc (ACTU) compare to its historical average?